That dude had nothing good to say about Ampio, how is that possible (and - or) legal? So how do I get a piece published on Seeking Alpha? Ampio has thousands of participants in three month trials, FDA has looked at the ongoing data and is set to respond. Clinical research organizations are working in this regard right now, who cares if it costs 12 million and requires a secondary offering to finance, that is a puny amount of shares anyway. Shorts might get hammered by any good news. We are expecting a 30 day response letter coming from the FDA any day now, what if that is a good one--- and with limited volume the shorts have to cover in addition to the heavy buying pressure.
That is what a binary event looks like, hit article or not.